BC stands out as a leading cause of cancer-related mortality among women globally
Unlike older GLP-1 medications that target only one hormone, tirzepatide is the first dual GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that offers greater benefits, including stronger appetite suppression, deeper metabolic changes, and more significant weight loss
Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights including variants in that shape your baseline GLP-1 receptor biology
Clinical evidence shows 90% of patients experience full hair regrowth within 6-12 months as weight stabilizes
Onofrj M, Ciccocioppo F, Varanese S, di Muzio A, Calvani M, Chiechio S, et al